TerminatedPhase 3NCT02887521

Pulmonary Rehabilitation Before Lung Cancer Resection

This is a study funded by the National Institute of Health. The rationale for the need of this research is the lack of any well proven risk-reducing intervention that may decrease the morbidity of lung cancer resection in patients with COPD or that may improve their quality of life trajectory, a meaningful outcome in the overall disease progression. The proposed intervention is unique as it combines exercise and behavioral interventions that were pilot tested in a randomized single-blinded controlled design in the proposed population and proved feasible and potentially effective. The aim is to test the effect of the proposed rehabilitation on length of stay, pulmonary complications and quality of life trajectory.

Checked against the public recordLast updated Feb 3, 2025 · Source: ClinicalTrials.gov

StatusTerminated
PhasePhase 3
U.S. locations7
SponsorAlliance for Clinical Trials in Oncology
01
Study overview

What this study is about

Purpose
Supportive Care
Study type
Interventional
Phase
Phase 3
Sponsor
Alliance for Clinical Trials in Oncology
Interventions being studied
Other: education; Procedure: rehabilitation; Device: pedometer; Other: education; Procedure: surgery
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

1. Patient is scheduled to undergo NSCLC resection: video assisted thoracoscopy (VATS) or open thoracotomy for: limited resection, lobectomy, or pneumonectomy. Surgery must not be scheduled to take place \< 3 weeks after registration. 2. Patient has a doctor diagnosis of COPD. 3. Patient is a current or ex-smoker with a smoking history of ≥ 10 pack years. (Calculated by multiplying the number of packs of cigarettes smoked per day by the number of years the person has smoked. For example, 1 pack-year is equal to smoking 20 cigarettes (1 pack) per day for 1 year, or 40 cigarettes per day for half a year, and so on). 4. Age ≥ 18 yrs

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • Mayo Clinic in FloridaJacksonville, Florida
  • Rush University Medical CenterChicago, Illinois
  • Henry Ford HospitalDetroit, Michigan
  • Mayo ClinicRochester, Minnesota
  • Baylor University Medical CenterDallas, Texas
  • Saint Vincent Hospital Cancer Center Green BayGreen Bay, Wisconsin
  • London Regional Cancer ProgramLondon, Ontario

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Feb 3, 2025. Always confirm current availability with the study team.

View original record ↗